MarginsXMarginsX
Home › Markets › Health Care › PLSE

Pulse Biosciences Inc Common Stock (DE) (PLSE)

PLSE trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$46.36
-8.09% on the day
Market cap
$3.4B
Mid cap
Revenue · 2025
$350K
Prior year not contiguous
Net income · 2025
-$72.8M
-20794.6% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1625101/000143774926004724/0001437749-26-004724-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerPLSE on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO year2016
SEC CIK0001625101
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$350K
Net income-$72.8M
Operating income-$76.9M
Net margin-20794.6%
Operating margin-21982.6%
Revenue growthNo prior-year revenue to compare
Cash$80.7M
Total assets$94.5M
P/E (computed)Net income was not positive
P/S (computed)9742.1×

Warning signs

Cash runway
7.0 months
$36.7M cash at September 30, 2026
Share count, 1 year
+8.5%
2025-10-31 to 2026-11-02 · +33.7% over 3 years
Going-concern doubt
No
10-Q filed November 5, 2026
Insider net buying, 12 months
$10.5M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-05
Cash and burn$36.7M cash; operating cash flow -$15.8M a quarter.Report 2026-09-30
Shares outstanding73,548,924 (2026-11-02); 67,767,578 a year earlier; 54,991,487 three years earlier.Cover page 2026-11-02
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 3 424B5 takedowns, 3 at the marketLatest 2026-09-15
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorDeloitte & Touche LLP, San Francisco, California, United StatesPCAOB Form AP 2026-02-24
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $13.5M, sold $3.0M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$395K-$23.1M-$15.3M$36.7MNo debt tags$1.5M10-Q 2026-11-05
Q2 2026
2026-06-30
$434K-$24.7M-$18.7M$101.6MNo debt tags$1.2M10-Q 2026-08-06
Q1 2026
2026-03-31
$401K-$18.6M-$14.6M$68.3MNo debt tags$751K10-Q 2026-05-14
Q4 2025
2025-12-31
$264K-$17.4M-$14.8M$80.7MNo debt tags$350K10-K 2026-02-19
Q3 2025
2025-09-30
$86K-$19.4M-$13.0M$95.2MNo debt tags$86K10-Q 2026-11-05
Q2 2025
2025-06-30
$0-$19.2M-$12.8M$106.3MNo debt tags$010-Q 2026-08-06
Q1 2025
2025-03-31
$0-$16.8M-$13.5M$119.3MNo debt tags$010-Q 2026-05-14
Q4 2024
2024-12-31
$0-$19.4M-$9.1M$118.0MNo debt tags$010-K 2026-02-19

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
FORM 424B5
424B52026-09-15
Latest annual report
FORM 10-K/A
10-K/A2026-04-30
Latest quarterly / interim
FORM 10-Q
10-Q2026-11-05
Latest current report
FORM 8-K
8-K2026-11-06
Latest proxy
FORM DEF 14A
DEF 14A2026-05-11

Source: SEC EDGAR submissions feed, 642 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-5.3%
1 month+3.9%
3 months+12.3%
Year to date+267.4%
1 year+256.7%
From 52-week high-13.3%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
IRTCiRhythm Holdings Inc.$90.83-1.18%$3.1B
NVSTEnvista Holdings Corporation$24.03-1.88%$3.9B
VVVVvVARDIS Holding AG$16.00-3.03%$2.9B
HTFLHeartflow Inc.$46.86-3.30%$4.1B
ATRCAtriCure Inc.$55.31-2.69%$2.8B
STVNStevanato Group S.p.A.$15.53-1.71%$4.2B
ICUIICU Medical Inc.$181.87+1.45%$4.5B
UFPTUFP Technologies Inc.$298.54-2.14%$2.3B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier